When comparing the top 20 ADRs reported by each HDAC inhibitor within the SOCs, it was observed that all three HDAC inhibitors exhibited different PTs of ADRs in the categories of Renal and Urinary Disorders, as well as Metabolism and Nutrition Disorders (see Table 5). This evidence concerns the gene HDAC9 and nutritional disorder.